ASRT Historical PE Ratio image   This ASRT PE ratio history page last updated 11/9/2022
ASRT Historical PE Ratio Chart
PeriodPriceAdj. EPSAnnualizedPE
Q3 2022
11/8/2022
2.620.220.883.0
Q2 2022
8/8/2022
3.650.281.123.3
Q1 2022
5/9/2022
1.880.381.521.2
Q4 2021
3/9/2022
2.600.100.406.5
Q3 2021
11/4/2021
1.110.080.323.5
Q2 2021
8/5/2021
1.33-0.32-1.28NA
Q1 2021
5/6/2021
2.000.120.484.2
Q4 2020
3/11/2021
3.80-0.24-0.96NA
Q3 2020
11/6/2020
1.92-0.36-1.44NA
Q2 2020
8/7/2020
3.12-1.12-4.48NA
Q1 2020
5/11/2020
3.480.401.602.2
Q4 2019
3/9/2020
4.28-0.56-2.24NA
Q3 2019
11/6/2019
2.920.963.840.8
Q2 2019
8/7/2019
10.641.004.002.7
Q1 2019
5/8/2019
18.960.923.685.2
Q4 2018
3/6/2019
16.601.204.803.5
Q3 2018
11/8/2018
20.281.686.723.0
Q2 2018
8/8/2018
31.080.763.0410.2
Q1 2018
5/10/2018
29.361.124.486.6
Q4 2017
2/27/2018
30.720.602.4012.8
Q3 2017
11/7/2017
18.240.562.248.1
Q2 2017
8/7/2017
36.920.321.2828.8
Q1 2017
5/9/2017
43.840.281.1239.1
Q4 2016
2/21/2017
63.081.927.688.2
Q3 2016
11/7/2016
91.561.124.4820.4
Q2 2016
8/3/2016
78.161.084.3218.1
Q1 2016
5/5/2016
64.600.481.9233.6
Q4 2015
2/22/2016
69.000.642.5627.0
Q3 2015
11/9/2015
80.441.325.2815.2
Q2 2015
7/29/2015
127.481.084.3229.5
Q1 2015
5/11/2015
97.64-0.52-2.08NA
Q4 2014
2/23/2015
82.000.843.3624.4
Q3 2014
11/5/2014
59.680.120.48124.3
Q2 2014
8/6/2014
44.840.040.16280.2
Q1 2014
5/8/2014
50.121.204.8010.4
Q4 2013
3/12/2014
54.002.8811.524.7
Q3 2013
11/5/2013
29.720.441.7616.9
Q2 2013
8/7/2013
25.760.040.16161.0
Q1 2013
5/8/2013
22.24-0.40-1.60NA
Q4 2012
2/20/2013
26.96-0.28-1.12NA
Q3 2012
11/5/2012
22.84-0.12-0.48NA
Q2 2012
8/2/2012
21.88-1.12-4.48NA
Q1 2012
5/8/2012
22.84-0.64-2.56NA
ASRT PE History Chart
PeriodPriceAdj. EPSTTMPE
Q3 2022
11/8/2022
2.620.220.982.7
Q2 2022
8/8/2022
3.650.280.844.3
Q1 2022
5/9/2022
1.880.380.247.8
Q4 2021
3/9/2022
2.600.10-0.02NA
Q3 2021
11/4/2021
1.110.08-0.36NA
Q2 2021
8/5/2021
1.33-0.32-0.80NA
Q1 2021
5/6/2021
2.000.12-1.60NA
Q4 2020
3/11/2021
3.80-0.24-1.32NA
Q3 2020
11/6/2020
1.92-0.36-1.64NA
Q2 2020
8/7/2020
3.12-1.12-0.32NA
Q1 2020
5/11/2020
3.480.401.801.9
Q4 2019
3/9/2020
4.28-0.562.321.8
Q3 2019
11/6/2019
2.920.964.080.7
Q2 2019
8/7/2019
10.641.004.802.2
Q1 2019
5/8/2019
18.960.924.564.2
Q4 2018
3/6/2019
16.601.204.763.5
Q3 2018
11/8/2018
20.281.684.164.9
Q2 2018
8/8/2018
31.080.763.0410.2
Q1 2018
5/10/2018
29.361.122.6011.3
Q4 2017
2/27/2018
30.720.601.7617.5
Q3 2017
11/7/2017
18.240.563.085.9
Q2 2017
8/7/2017
36.920.323.6410.1
Q1 2017
5/9/2017
43.840.284.4010.0
Q4 2016
2/21/2017
63.081.924.6013.7
Q3 2016
11/7/2016
91.561.123.3227.6
Q2 2016
8/3/2016
78.161.083.5222.2
Q1 2016
5/5/2016
64.600.483.5218.4
Q4 2015
2/22/2016
69.000.642.5227.4
Q3 2015
11/9/2015
80.441.322.7229.6
Q2 2015
7/29/2015
127.481.081.5283.9
Q1 2015
5/11/2015
97.64-0.520.48203.4
Q4 2014
2/23/2015
82.000.842.2037.3
Q3 2014
11/5/2014
59.680.124.2414.1
Q2 2014
8/6/2014
44.840.044.569.8
Q1 2014
5/8/2014
50.121.204.5611.0
Q4 2013
3/12/2014
54.002.882.9618.2
Q3 2013
11/5/2013
29.720.44-0.20NA
Q2 2013
8/7/2013
25.760.04-0.76NA
Q1 2013
5/8/2013
22.24-0.40-1.92NA
Q4 2012
2/20/2013
26.96-0.28-2.16NA
Q3 2012
11/5/2012
22.84-0.12NANA
Q2 2012
8/2/2012
21.88-1.12NANA
Q1 2012
5/8/2012
22.84-0.64NANA
Quotes delayed 20 minutes

Email EnvelopeFree ASRT Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Assertio Therapeutics (ASRT) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

ATEC PE Ratio History
ATHA PE Ratio History
ATHX PE Ratio History
ATIP PE Ratio History
ATNF PE Ratio History
ATNX PE Ratio History
ATOS PE Ratio History
ATRA PE Ratio History
ATRC PE Ratio History
ATRI PE Ratio History
How should the ASRT historical PE ratio be determined?
Realizing that PE stands for Price to Earnings ratio, we need two values to compute it: stock price and earnings per share. The stock price at any given date is a known historical value, but what about the earnings number to use?

✔️Accepted answer: There are a number of different approaches when it comes to calculating a historical PE ratio for a company like Assertio Therapeutics. We like to take our measurements on each of the past quarterly earnings reports. That only leaves the question of whether the earnings number at that quarterly report should be used on an annualized basis, or some other method. We approach this question using three different methods, on this ASRT Historical PE Ratio page.

What is the average historical PE for ASRT based on annualized quarterly earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use that quarter's earnings result annualized?

✔️Accepted answer: The ASRT historical PE ratio using the annualized quarterly earnings method works out to 28.7.

What is the average historical PE for ASRT based on trailing twelve month earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the trailing twelve months combined earnings result in the calculation?

✔️Accepted answer: The ASRT historical PE ratio using the TTM earnings method works out to 21.2.

What is the average historical PE for ASRT based on median TTM earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the median earnings over the trailing twelve months and annualize that median result in the calculation?

✔️Accepted answer: The ASRT historical PE ratio using the annualized median TTM earnings method works out to 1.

On this page we presented the ASRT Historical PE Ratio information for Assertio Therapeutics' stock. The average ASRT historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 28.7. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average ASRT historical PE based on this TTM earnings result method is 21.2. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this ASRT historical PE result, against the recent PE: when this page was posted on 11/8/2022, the most recent closing price for ASRT had been 2.62, and the most recent quarterly earnings result, annualized, was 0.88. Meanwhile, the most recent TTM earnings summed to 0.98. From these numbers, we calculate the recent ASRT PE on 11/8/2022 based on annualized quarterly EPS was 3.0. Based on ASRT's history, that recent PE is low relative to the historical average, with the recent PE 89.5% lower than the historical average PE across our data set for Assertio Therapeutics. Looking at the recent ASRT PE on 11/8/2022 based on TTM EPS, we calculate the ratio at 2.7. Based on ASRT's history, that recent PE is low relative to the historical average, with the recent PE 87.3% lower than the average PE across our Assertio Therapeutics data set with TTM EPS used in the calculation at each period.

Another interesting ASRT historical PE Ratio calculation we look at is to take the median earnings per share of the last four quarters for ASRT, and then annualize the resulting value... with that annualized number then being used in the PE calculation. To walk through this math for ASRT, we start with the past four EPS numbers and we first sort them from lowest to highest: 0.10, 0.22, 0.28, and 0.38. We then toss out the highest and lowest result, and then take the average of those two middle numbers — 0.22 and 0.28 — which gives us the median of 0.25. Basically the way to think about this 0.25 number is this: for the trailing four earnings reports, 0.25 marks the "middle ground" number where ASRT has reported a value higher than 0.25 half the time, and has reported a value lower than 0.25 half the time. Annualizing that median value then gets us to 1/share, which we use as the denominator in our next PE calculation. With 2.62 as the numerator (as of 11/8/2022), the calculation is then 2.62 / 1 = 2.6 as the ASRT PE ratio as of 11/8/2022, based on that annualized median value we calculated.

For self directed investors doing their due diligence on ASRT or any other given stock, valuation analysis for ASRT can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Assertio Therapeutics PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for ASRT. Thanks for visiting, and the next time you need to research ASRT Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.

Recommended: BPSM Videos, RES market cap history, ELD Dividend History.

 

ASRT Historical PE Ratio | www.HistoricalPERatio.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.